Trials / Completed
CompletedNCT01061073
Evaluation of the Efficacy of Tamsulosin (Alpha Blockers) Compared to Phloroglucinol in Improving JJ Ureteral Stent Tolerance. A Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 73 (actual)
- Sponsor
- Poitiers University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
JJ ureteral stent represents an advance in the management of the upper urinary tract obstruction as it allows the patient to resume his activities although he is stented between the kidney and the bladder. However, in many cases, this JJ stent is not well tolerated and can even be unbearable. This trial evaluates the benefit of tamsulosin (an alpha-blocker) in improving the tolerance of JJ stents compared to low-doses of phloroglucinol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Omexel | |
| DRUG | spasfon |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2012-10-01
- First posted
- 2010-02-02
- Last updated
- 2016-10-11
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01061073. Inclusion in this directory is not an endorsement.